Providers can continue treating uninsured patients with the monoclonal antibody bebtelovimab after the product went on the commercial market last week because of a plan implemented by the North Carolina Department of Health and Human Services.
FRAUD ALERT
Be aware of multiple fraudulent text scams requesting payment for NCDMV fees, fines or tolls. NCDMV will NEVER request payment by text. Please report it as spam and delete. Learn More About NCDMV Fraudulent Text Scams